1. Report Overview

1.1 The OTC Pharmaceuticals Market Overview

1.2 Research Methodology

1.3 Global OTC Pharmaceutical Market Segmentation

1.4 Why You Should Read This Report

1.5 How this report delivers?

1.6 Key Questions Answered by This Analytical Report

1.7 Frequently Asked Questions (FAQ)

1.8 Who is This Report For?

1.9 Associated Visiongain Reports

1.10 About Visiongain

2. Introduction to OTC Pharmaceuticals

2.1 What Are OTC Pharmaceuticals?

2.2 Classification of OTC Pharmaceuticals

2.3 What are the Requirements for an OTC Pharmaceutical Drug?

2.4 OTC Switching

2.4.1 How Is a Drug Switched from Prescription to OTC?

2.5 Manufacturing and Distribution of OTC Pharmaceuticals

2.6 Regulation of OTC Pharmaceuticals

2.6.1 Regulation of OTC Pharmaceuticals in the US

2.6.2 Regulation of OTC Pharmaceuticals in Japan: Deregulating the Sales of OTCs

2.6.3 Regulation of OTC Pharmaceuticals in Europe

2.6.4 Regulation of OTC Pharmaceuticals in China

2.6.5 Regulation of OTC Pharmaceuticals in Others Countries

3. Global OTC Pharmaceutical Market Forecast 2018-2028

3.1 The Current State of the OTC Pharmaceutical Market

4. Global OTC Pharmaceutical Market by Product: Market Forecast 2018-2028

4.1 Overview

4.2 Cough, Cold and Allergy

4.2.1 Anti-Allergy Products

4.3 Analgesics

4.3.1 Internal Analgesics

4.3.2 External Analgesics

4.4 Gastrointestinal

4.5 Dermatological

4.5.1 Minor Cuts and Wounds

4.5.2 Acne

4.5.3 Rashes, Itchy Skin, and Dermatitis/Eczema

4.5.4 Cold Sores

4.5.5 Warts

4.5.6 Fungal Skin Infections

4.5.7 Haemorrhoids

4.5.8 Other Dermatological Products

4.6 Eye Care

4.6.1 Dry Eye Syndrome

4.6.2 Bacterial Conjunctivitis

4.6.3 Ocular Allergy and Allergic Conjunctivitis

4.6.4 Treatment of Ocular Allergy/ Allergic Conjunctivitis

4.7 Smoking Cessation Aids

4.8 Other Products

5. Global OTC Pharmaceutical Market by National Market: Market Forecast 2018-2028

5.1 Global OTC Pharmaceuticals Market: Regional Forecast, 2018-2028

5.2 North American OTC Pharmaceutical Market Forecasts 2018-2028

5.2.1 USA OTC Pharmaceutical Market Forecasts 2018-2028

5.2.2 Canada OTC Pharmaceutical Market Forecasts 2018-2028

5.2.3 Mexico OTC Pharmaceutical Market Forecasts 2018-2028

5.3 South American OTC Pharmaceutical Market Forecasts 2018-2028

5.3.1 Brazil OTC Pharmaceutical Market Forecasts 2018-2028

5.3.2 Argentina OTC Pharmaceutical Market Forecasts 2018-2028

5.3.3 Paraguay OTC Pharmaceutical Market Forecasts 2018-2028

5.3.4 Bolivia OTC Pharmaceutical Market Forecasts 2018-2028

5.3.5 Rest of South America OTC Pharmaceutical Market Forecasts 2018-2028

5.4 European OTC Pharmaceutical Market Forecasts 2018-2028

5.4.1 France OTC Pharmaceutical Market Forecasts 2018-2028

5.4.2 Germany OTC Pharmaceutical Market Forecasts 2018-2028

5.4.3 UK OTC Pharmaceutical Market Forecasts 2018-2028

5.4.4 Spain OTC Pharmaceutical Market Forecasts 2018-2028

5.4.5 Italy OTC Pharmaceutical Market Forecasts 2018-2028

5.4.6 Rest of Europe OTC Pharmaceutical Market Forecasts 2018-2028

5.5 Asia-Pacific OTC Pharmaceutical Market Forecasts 2018-2028

5.5.1 China OTC Pharmaceutical Market Forecasts 2018-2028

5.5.2 Japan OTC Pharmaceutical Market Forecasts 2018-2028

5.5.3 India OTC Pharmaceutical Market Forecasts 2018-2028

5.5.4 Australia OTC Pharmaceutical Market Forecasts 2018-2028

5.5.5 Thailand OTC Pharmaceutical Market Forecasts 2018-2028

5.5.6 Rest of Asia-Pacific OTC Pharmaceutical Market Forecasts 2018-2028

5.6 Rest of World OTC Pharmaceutical Market Forecasts 2018-2028

5.6.1 Middle East OTC Pharmaceutical Market Forecasts 2018-2028

5.6.2 Africa OTC Pharmaceutical Market Forecasts 2018-2028

5.6.3 Other Countries OTC Pharmaceutical Market Forecasts 2018-2028

6. Qualitative Analysis of the OTC Pharmaceutical Market, 2018-2028

6.1 SWOT Analysis of the OTC Pharmaceutical Market

6.2 Strengths

6.2.1 Healthcare Systems, Third Party Payers, and Manufacturers: All have Incentives to Push for OTC Drug Consumption

6.2.1.1 Manufacturers Can Reap OTC Sales Benefits

6.2.1.2 Third Party Payers: Reducing the Cost Burden

6.2.1.3 Healthcare Systems: Pushing the Cost to the Consumer

6.2.2 Many Pharmaceutical Companies Have a Strong Potential OTC Portfolio

6.2.3 Regulators Are Encouraging OTC Approvals

6.2.4 Effective Distribution Networks Due to Expansion of Retail Pharmacy and Alternative Distributors

6.2.5 Deterring the Consumption of Counterfeit Drugs

6.2.6 Cultural Changes Will Support Self-Medication with OTC Medicines

6.3 Weaknesses

6.3.1 Pharma Companies Remain Focused on Prescription Drugs

6.3.2 Manufacturing Problems Affects Sales and Reputation of OTC Drugs

6.3.3 OTC Products are Vulnerable to Price Controls by Governments

6.3.4 Downward Cost Pressures of OTC Drugs

6.4 Opportunities

6.4.1 Demographic and Economic Changes Will Create Growth Opportunities

6.4.2 New OTC Switch Categories

6.4.3 Strong Growth in Emerging Markets

6.4.4 New Healthcare Technologies May enable OTC Approvals

6.4.5 Opportunities to Drive Sales via Social Media and Online Marketing

6.4.6 Self-Medication Can Reduce the Under Treatment of Disease

6.5 Threats

6.5.1 Competition from Private-Label Brands Will Reduce Profitability

6.5.2 Regulatory Concerns Over Safety and Misuse may Lead to Withdrawal of Products

6.5.3 Resistance to OTC Switching from Some Groups in Certain Countries

6.6 Porter’s Five Forces Analysis of the OTC Pharmaceutical Market

6.6.1 Rivalry Among Competitors [High]

6.6.2 Threat of New Entrants [Medium]

6.6.3 Power of Suppliers [Low]

6.6.4 Power of Buyers [Medium]

6.6.5 Threats of Substitutes [Medium]

7. Leading Companies in the OTC Pharmaceutical Market

7.1 Bayer AG

7.1.1 Bayer AG: Company Overview

7.1.2 Bayer AG: Product Portfolio

7.1.3 Bayer AG: Recent Developments

7.2 GlaxoSmithKline PLC (GSK Consumer Care)

7.2.1 GlaxoSmithKline PLC: Company Overview

7.2.2 GlaxoSmithKline PLC: Product Portfolio

7.2.3 GlaxoSmithKline PLC: Recent Developments

7.3 Johnson & Johnson

7.3.1 Johnson & Johnson: Company Overview

7.3.2 Johnson & Johnson: Product Portfolio

7.3.3 Johnson & Johnson: Recent Developments

7.4 Perrigo Company PLC

7.4.1 Perrigo Company PLC: Company Overview

7.4.2 Perrigo Company PLC: Product Portfolio

7.4.3 Perrigo Company PLC: Recent Developments

7.5 Daiichi Sankyo Co., Ltd.

7.5.1 Daiichi Sankyo Co., Ltd.: Company Overview

7.5.2 Daiichi Sankyo Co., Ltd.: Recent Developments

7.6 Pfizer Inc.

7.6.1 Pfizer Inc.: Company Overview

7.6.2 Pfizer Inc.: Product Portfolio

7.6.3 Pfizer Inc.: Recent Developments

7.7 Procter & Gamble

7.7.1 Procter & Gamble: Company Overview

7.7.2 Procter & Gamble: Product Portfolio

7.7.3 Procter & Gamble: Recent Developments

7.8 Sanofi S.A.

7.8.1 Sanofi S.A.: Company Overview

7.8.2 Sanofi S.A.: Product Portfolio

7.8.3 Sanofi S.A: Recent Developments

7.9 Reckitt Benckiser Group PLC

7.9.1 Reckitt Benckiser Group PLC: Company Overview

7.9.2 Reckitt Benckiser Group PLC: Product Portfolio

7.9.3 Reckitt Benckiser Group PLC: Recent Developments

7.10 Cipla Inc.

7.10.1 Cipla Inc.: Company Overview

7.10.2 Cipla Inc.: Product Portfolio

7.10.3 Cipla Inc.: Recent Developments

7.11 List of Key Players in Global OTC Market

8. Conclusions

8.1 The World OTC Pharmaceutical Market in 2016-2017

8.1.1 The Leading OTC Product Categories

8.1.2 Leading National Markets: Emerging Market Represent a Large Proportion

8.1.3 The Global OTC Market Growth Factors

8.1.4 Potential OTC Switching, 2018-2028

8.1.5 Emerging OTC Markets

8.2 Concluding Remarks

9. Glossary

Associated Visiongain Reports

Visiongain Report Sales Order Form

Appendix A

About Visiongain

Appendix B

Visiongain report evaluation form

List of Figures

Figure 1.1 OTC Pharmaceuticals: Overview of Submarkets

Figure 2.1 The OTC Pharmaceutical Supply Chain, 2018

Figure 3.1 OTC Pharmaceutical Market, by Product, ($bn), 2018-2028

Figure 3.2 OTC Pharmaceutical Market, by Geography, ($bn), 2018-2028

Figure 4.1 OTC Pharmaceutical Market, by Product, Market Share (%), 2017

Figure 4.2 OTC Pharmaceutical Market, by Product, Forecast ($bn) 2018-2028

Figure 4.3 OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, by Geography, ($bn) 2018-2028

Figure 4.4 OTC Pharmaceutical Market for Analgesics Market Forecast, by Geography ($bn) 2018-2028

Figure 4.5 OTC Pharmaceutical Market for Gastrointestinal Market Forecast, by Geography, ($bn) 2018-2028

Figure 4.6 OTC Pharmaceutical Market for Dermatological Market Forecast, by Geography, ($bn) 2018-2028

Figure 4.7 OTC Pharmaceutical Market for Eye Care Market Forecast, by Geography($bn) 2018-2028

Figure 4.8 OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, by Geography, ($bn) 2018-2028

Figure 4.9 OTC Pharmaceutical Market for Other Products Market Forecast, by Geography($bn) 2018-2028

Figure 5.1 OTC Pharmaceutical Market Forecast, by Geography ($bn) 2018-2028

Figure 5.2 Global OTC Pharmaceutical Market, by Geography, Market Share (%), 2017

Figure 5.3 North America OTC Pharmaceutical Market Forecast, by Country ($bn) 2018-2028

Figure 5.4 North America OTC Pharmaceutical Market, by Country, Market Share (%), 2017

Figure 5.5 USA OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.6 Canada OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.7 Mexico OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.8 South America OTC Pharmaceutical Market Forecast, by Country ($bn) 2018-2028

Figure 5.9 South America OTC Pharmaceutical Market, by Country, Market Share (%), 2017

Figure 5.10 Brazil OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.11 Argentina OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.12 Paraguay OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.13 Bolivia OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.14 Rest of South America OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.15 Europe OTC Pharmaceutical Market Forecast, by Country($bn) 2018-2028

Figure 5.16 Europe OTC Pharmaceutical Market, by Country, Market Share (%), 2016

Figure 5.17 France OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.18 Germany OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.19 UK OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.20 Spain OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.21 Italy OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.22 Rest of Europe OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.23 Asia-Pacific OTC Pharmaceutical Market Forecast, by Country ($billion) 2018-2028

Figure 5.24 Asia-Pacific OTC Pharmaceutical Market, by Country, Market Share (%), 2016

Figure 5.25 China OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.26 Japan OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.27 India OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.28 Australia OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.29 Thailand OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.30 Rest of Asia-Pacific OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.31 RoW OTC Pharmaceutical Market Forecast, by Country ($bn) 2018-2028

Figure 5.32 Rest of World OTC Pharmaceutical Market, by Country, Market Share (%), 2016

Figure 5.33 Middle East OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.34 Africa OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 5.35 Other Countries OTC Pharmaceutical Market Forecast ($bn) 2018-2028

Figure 6.1 Porter’s Five Analysis of the OTC Pharmaceutical Market , 2017

Figure 7.1 Bayer AG, Revenue, ($million), 2012-2016

Figure 7.2 Bayer AG, Product Segments Share (%), 2016

Figure 7.3 Bayer AG, Geographic Presence Share (%), 2016

Figure 7.4 GlaxoSmithKline PLC, Revenue, ($million), 2012-2016

Figure 7.5 GlaxoSmithKline PLC, Product Segments Share (%), 2016

Figure 7.6 GlaxoSmithKline PLC, Geographical Presence Share (%), 2016

Figure 7.7 Johnson & Johnson, Revenue, ($million), 2012-2016

Figure 7.8 Johnson & Johnson, Product Segments Share (%), 2016

Figure 7.9 Johnson & Johnson, Geographical Presence Share (%), 2016

Figure 7.10 Perrigo Company PLC, Revenue, ($million), 2012-2016

Figure 7.11 Perrigo Company PLC, Product Segments Share (%), 2016

Figure 7.12 Perrigo Company PLC, Geographical Presence Share (%), 2016

Figure 7.13 Daiichi Sankyo Co., Ltd., Revenue, ($million), 2013-2017

Figure 7.14 Daiichi Sankyo Co., Ltd., Product Segments Share (%), 2017

Figure 7.15 Daiichi Sankyo Co., Ltd., Geographical Presence Share (%), 2017

Figure 7.16 Pfizer Inc., Revenue, ($million), 2012-2016

Figure 7.17 Pfizer Inc., Product Segments Share (%), 2016

Figure 7.18 Pfizer Inc., Geographical Presence Share (%), 2016

Figure 7.19 Procter & Gamble, Revenue, ($million), 2012-2016

Figure 7.20 Procter & Gamble, Product Segments Share (%), 2017

Figure 7.21 Procter & Gamble, Geographical Presence Share (%), 2017

Figure 7.22 Sanofi S.A., Revenue, ($million), 2012-2016

Figure 7.23 Sanofi S.A., Product Segments Share (%), 2016

Figure 7.24 Sanofi S.A., Geographical Presence Share (%), 2016

Figure 7.25 Reckitt Benckiser Group PLC, Revenue, ($million), 2012-2016

Figure 7.26 Reckitt Benckiser Group PLC, Product Segments Share (%), 2016

Figure 7.27 Cipla Inc., Revenue, ($million), 2012-2016

Figure 7.28 Cipla Inc., Product Segments Share (%), 2016

Figure 8.1 Global OTC Pharmaceutical Market Revenue, by Product Type ($bn), 2018-2028

Figure 8.2 Global OTC Pharmaceutical Market Revenue, by Geography ($bn), 2018-2028

List of Tables

Table 3.1 Global OTC Pharmaceutical Market Forecast ($bn, AGR%, CAGR%) 2018-2028

Table 4.1 Global OTC Pharmaceutical Market Forecast, by Product ($bn, AGR%) 2018-2028

Table 4.2 OTC Cough, Cold and Allergy Active Ingredients, 2018

Table 4.3 Global OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, ($bn, AGR%) 2018-2028

Table 4.4 OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, by Geography, ($bn, AGR%) 2018-2028

Table 4.5 OTC Internal Analgesic Active Ingredients, 2017

Table 4.6 OTC External Analgesic Active Ingredients, 2017

Table 4.7 Global OTC Pharmaceutical Market for Analgesics Market Forecast, ($bn, AGR%) 2018-2028

Table 4.8 OTC Pharmaceutical Market for Analgesics Market Forecast, by Geography ($bn, AGR%) 2018-2028

Table 4.9 Global OTC Pharmaceutical Market for Gastrointestinal Market Forecast, ($bn, AGR%) 2018-2028

Table 4.10 OTC Pharmaceutical Market for Gastrointestinal Market Forecast, by Geography ($bn, AGR%) 2018-2028

Table 4.11 OTC Antifungal Active Ingredients, 2017

Table 4.12 Global OTC Pharmaceutical Market for Dermatological Market Forecast, ($bn, AGR%) 2018-2028

Table 4.13 OTC Pharmaceutical Market for Dermatological Market Forecast, by Geography, ($bn, AGR%) 2018-2028

Table 4.14 OTC Dry Eye Syndrome Active Ingredients, 2017

Table 4.15 OTC Bacterial Conjunctivitis Active Ingredients, 2017

Table 4.16 OTC Ocular Allergy Active Ingredients, 2017

Table 4.17 Global OTC Pharmaceutical Market for Eye Care Market Forecast, ($bn, AGR%) 2018-2028

Table 4.18 OTC Pharmaceutical Market for Eye Care Market Forecast, by Geography ($bn, AGR%) 2018-2028

Table 4.19 OTC Smoking Cessation Aid Active Ingredients, 2017

Table 4.20 Global OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, ($bn, AGR%) 2018-2028

Table 4.21 OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, by Geography ($bn, AGR%) 2018-2028

Table 4.22 Global OTC Pharmaceutical Market for Other Products Market Forecast, ($bn, AGR%) 2018-2028

Table 4.23 OTC Pharmaceutical Market for Other Products Market Forecast, by Geography ($bn, AGR%) 2018-2028

Table 5.1 OTC Pharmaceutical Market Forecast, by Geography ($bn, AGR%) 2018-2028

Table 5.2 North America OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2018-2028

Table 5.3 USA OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.4 Canada OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.5 Mexico OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.6 South America OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2018-2028

Table 5.7 Brazil OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.8 Argentina OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.9 Paraguay OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.10 Bolivia OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.11 Rest of South America OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.12 European OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2018-2028

Table 5.13 France OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.14 Germany OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.15 UK OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.16 Spain OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.17 Italy OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.18 Rest of European OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.19 Asia-Pacific OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2018-2028

Table 5.20 China OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.21 Selected Leading Companies in the Japanese OTC Pharma Market, 2017

Table 5.22 Japan OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.23 India OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.24 Australia OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.25 Thailand OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.26 Rest of Asia-Pacific OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.27 Rest of World OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2018-2028

Table 5.28 Middle East OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.29 Africa OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 5.30 Other Countries OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2018-2028

Table 7.1 Bayer AG: Company Overview

Table 7.2 Bayer AG: Product Portfolio

Table 7.3 Bayer AG: Recent Developments

Table 7.4 GlaxoSmithKline PLC: Company Overview

Table 7.5 GlaxoSmithKline PLC: Product Portfolio

Table 7.6 GlaxoSmithKline PLC: Recent Developments

Table 7.7 Johnson & Johnson: Company Overview

Table 7.8 Johnson & Johnson: Product Portfolio

Table 7.9 Johnson & Johnson: Recent Developments

Table 7.10 Perrigo Company PLC: Company Overview

Table 7.11 Perrigo Company PLC: Product Portfolio

Table 7.12 Perrigo Company PLC: Recent Developments

Table 7.13 Daiichi Sankyo Co., Ltd.: Company Overview

Table 7.14 Daiichi Sankyo Co., Ltd.: Recent Developments

Table 7.15 Pfizer Inc.: Company Overview

Table 7.16 Pfizer Inc.: Product Portfolio

Table 7.17 Pfizer Inc.: Recent Developments

Table 7.18 Procter & Gamble: Company Overview

Table 7.19 Procter & Gamble: Product Portfolio

Table 7.20 Procter & Gamble: Recent Developments

Table 7.21 Sanofi S.A.: Company Overview

Table 7.22 Sanofi S.A.: Product Portfolio

Table 7.23 Sanofi S.A: Recent Developments

Table 7.24 Reckitt Benckiser Group PLC: Company Overview

Table 7.25 Reckitt Benckiser Group PLC: Product Portfolio

Table 7.26 Reckitt Benckiser Group PLC: Recent Developments

Table 7.27 Cipla Inc.: Company Overview

Table 7.28 Cipla Inc.: Product Portfolio

Table 7.29 Cipla Inc.: Recent Developments

Table 7.30 List of Key Players in Global OTC Market